AnalystsDouglas MiehmDouglas Miehm's Stock Forecasts
AnalystsDouglas Miehm
Analyst Ranking
Bottom 4%
#4763 out of 4929 analysts
Average Return
-11.2%
Win Rate
34%11 out of 32
Risk vs Reward
Poor
Good
Douglas Miehm's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aurinia Pharmaceuticals IncAUPH | +59.81% | $5.15 | $8.23 | 2022-11-04 - 2023-11-03 | Buy |
Oncolytics Biotech IncONCY | +43.30% | $0.64 | $0.92 | 2025-03-10 - 2025-07-03 | Buy |
Aurinia Pharmaceuticals IncAUPH | +33.16% | $5.85 | $7.79 | 2024-02-16 - 2025-02-14 | Buy |
Bausch & Lomb CorpBLCO | +29.12% | $15.35 | $19.82 | 2022-07-26 - 2023-07-25 | Buy |
Aurinia Pharmaceuticals IncAUPH | +25.74% | $6.72 | $8.45 | 2023-01-04 - 2024-01-03 | Buy |
Douglas Miehm Analyst Color
Get additional color on Douglas Miehm's coverage of popular stocks
Douglas Miehm's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bausch Health Companies IncBHC | 19 | Hold | $10.00 | +41.64% | Maintains | 2 months ago |
Bausch & Lomb CorpBLCO | 13 | Buy | $17.00 | +22.48% | Maintains | 3 months ago |
Oncolytics Biotech IncONCY | 1 | Buy | $5.00 | +443.48% | Maintains | 4 months ago |
Ligand Pharmaceuticals IncLGND | 5 | Buy | $143.00 | +24.80% | Maintains | 7 months ago |
Aurinia Pharmaceuticals IncAUPH | 8 | Buy | $8.00 | N/A | Maintains | a year ago |
Crh Medical CorpCRHM | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Novadaq Technologies IncNVDQ1 | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.